319 related articles for article (PubMed ID: 25358076)
21. Combined statistical analyses for long-term stability data with multiple storage conditions: a simulation study.
Almalik O; Nijhuis MB; van den Heuvel ER
J Biopharm Stat; 2014; 24(3):493-506. PubMed ID: 24697656
[TBL] [Abstract][Full Text] [Related]
22. Arrhenius time-scaled least squares: a simple, robust approach to accelerated stability data analysis for bioproducts.
Rauk AP; Guo K; Hu Y; Cahya S; Weiss WF
J Pharm Sci; 2014 Aug; 103(8):2278-86. PubMed ID: 24974956
[TBL] [Abstract][Full Text] [Related]
23. Evaluating the performance of the ICH guidelines for shelf life estimation.
Quinlan M; Stroup W; Schwenke J; Christopher D
J Biopharm Stat; 2013; 23(4):881-96. PubMed ID: 23786363
[TBL] [Abstract][Full Text] [Related]
24. A scientific and statistical analysis of accelerated aging for pharmaceuticals. Part 1: accuracy of fitting methods.
Waterman KC; Swanson JT; Lippold BL
J Pharm Sci; 2014 Oct; 103(10):3000-6. PubMed ID: 25043838
[TBL] [Abstract][Full Text] [Related]
25. Predicting accelerated aggregation rates for monoclonal antibody formulations, and challenges for low-temperature predictions.
Brummitt RK; Nesta DP; Roberts CJ
J Pharm Sci; 2011 Oct; 100(10):4234-43. PubMed ID: 21671226
[TBL] [Abstract][Full Text] [Related]
26. A comparison of drug substance predicted chemical stability with ICH compliant stability studies.
Williams HE; Bright J; Roddy E; Poulton A; Cosgrove SD; Turner F; Harrison P; Brookes A; MacDougall E; Abbott A; Gordon C
Drug Dev Ind Pharm; 2019 Mar; 45(3):379-386. PubMed ID: 30395722
[TBL] [Abstract][Full Text] [Related]
27. A statistical approach to determining criticality of residual host cell DNA.
Yang H; Wei Z; Schenerman M
J Biopharm Stat; 2015; 25(2):234-46. PubMed ID: 25358029
[TBL] [Abstract][Full Text] [Related]
28. Adjusting dissolution specifications for the variability induced by storage conditions.
Reynolds JM; Rogers DH
J Biopharm Stat; 2000 Aug; 10(3):425-31. PubMed ID: 10959921
[TBL] [Abstract][Full Text] [Related]
29. Estimation of the shelf-life of drugs with mixed effects models.
Chen JJ; Hwang JS; Tsong Y
J Biopharm Stat; 1995 Mar; 5(1):131-40. PubMed ID: 7613558
[TBL] [Abstract][Full Text] [Related]
30. Accelerated stability testing of bioproducts: attractions and pitfalls.
Franks F
Trends Biotechnol; 1994 Apr; 12(4):114-7. PubMed ID: 7764806
[TBL] [Abstract][Full Text] [Related]
31. Simple Approach to Calculate Random Effects Model Tolerance Intervals to Set Release and Shelf-Life Specification Limits of Pharmaceutical Products.
Montes RO; Burdick RK; Leblond DJ
PDA J Pharm Sci Technol; 2019; 73(1):39-59. PubMed ID: 30361286
[TBL] [Abstract][Full Text] [Related]
32. Establishment of an equivalence acceptance criterion for accelerated stability studies.
Burdick RK; Sidor L
J Biopharm Stat; 2013; 23(4):730-43. PubMed ID: 23799811
[TBL] [Abstract][Full Text] [Related]
33. Statistical evaluation for stability studies under stress storage conditions.
Gil-Alegre ME; Bernabeu JA; Camacho MA; Torres-Suarez AI
Farmaco; 2001 Nov; 56(11):877-83. PubMed ID: 11765040
[TBL] [Abstract][Full Text] [Related]
34. Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions.
Sood J; Sapra B; Bhandari S; Jindal M; Tiwary AK
Ther Deliv; 2014 Oct; 5(10):1123-42. PubMed ID: 25418270
[TBL] [Abstract][Full Text] [Related]
35. The application of electrochemistry to pharmaceutical stability testing--comparison with in silico prediction and chemical forced degradation approaches.
Torres S; Brown R; Szucs R; Hawkins JM; Zelesky T; Scrivens G; Pettman A; Taylor MR
J Pharm Biomed Anal; 2015 Nov; 115():487-501. PubMed ID: 26299525
[TBL] [Abstract][Full Text] [Related]
36. Estimating shelf-life of drugs in solution.
Newton DW; Miller KW
Am J Hosp Pharm; 1987 Jul; 44(7):1633-40. PubMed ID: 3631095
[TBL] [Abstract][Full Text] [Related]
37. The application of the Accelerated Stability Assessment Program (ASAP) to quality by design (QbD) for drug product stability.
Waterman KC
AAPS PharmSciTech; 2011 Sep; 12(3):932-7. PubMed ID: 21748541
[TBL] [Abstract][Full Text] [Related]
38. Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances.
Bao Y; Mo X; Xu X; He Y; Xu X; An H
J Pharm Biomed Anal; 2008 Nov; 48(3):664-71. PubMed ID: 18678459
[TBL] [Abstract][Full Text] [Related]
39. A simulation study with statistical evaluation for the determination of non-isothermal kinetics conditions in drugs stability.
Fernández de Aránguiz MY; de la Torre S; Berraondo MR
Eur J Pharm Sci; 2007 Aug; 31(5):277-87. PubMed ID: 17540544
[TBL] [Abstract][Full Text] [Related]
40. Predicting drug hydrolysis based on moisture uptake in various packaging designs.
Naversnik K; Bohanec S
Eur J Pharm Sci; 2008 Dec; 35(5):447-56. PubMed ID: 18940251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
